Loading...
Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
Immunotherapies are becoming increasingly important in the treatment armamentarium of a variety of malignancies. Immune checkpoint inhibitors are the most representative drugs receiving regulatory approval over the past few years. In a recent study published in Clinical Cancer Research, we demonstra...
Na minha lista:
| Udgivet i: | Integr Cancer Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247554/ https://ncbi.nlm.nih.gov/pubmed/30229677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735418801524 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|